LIGHT/TNFSF14 promotes CAR-T cell trafficking and cytotoxicity through reversing immunosuppressive tumor microenvironment-Reference-Cited by-同舟云学术

LIGHT/TNFSF14 promotes CAR-T cell trafficking and cytotoxicity through reversing immunosuppressive tumor microenvironment

Published:2023-09 Issue:9 Volume:31 Page:2575-2590
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Zhang Na,Liu Xiaohong,Qin Juliang,Sun Yue,Xiong Hao,Lin Boxu,Liu Kexin,Tan Binghe,Zhang Chenglin,Huang Chenshen,Ren Shancheng,Liu Mingyao,Du Bing^ORCID

Funder

East China Normal University

National Key Research and Development Program of China

National Key Research and Development Program of China Stem Cell and Translational Research

Shanghai Science and Technology Development Foundation

School of Life Sciences and Biotechnology Division of Life Sciences, Korea University

Science and Technology Commission of Shanghai Municipality

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference31 articles.

1. Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia;Park;N. Engl. J. Med.,2018

2. Supercharging adoptive T cell therapy to overcome solid tumor–induced immunosuppression;Mardiana;Sci. Transl. Med.,2019

3. Engineering NK Cells Modified With an EGFRvIII-specific Chimeric Antigen Receptor to Overexpress CXCR4 Improves Immunotherapy of CXCL12/SDF-1alpha-secreting Glioblastoma;Müller;J. Immunother.,2015

4. Transiently redirected T cells for adoptive transfer;Almåsbak;Cytotherapy,2011

5. A myriad of functions and complex regulation of the CCR7/CCL19/CCL21 chemokine axis in the adaptive immune system;Comerford;Cytokine Growth Factor Rev.,2013

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular mechanism of co-stimulatory domains in promoting CAR-T cell anti-tumor efficacy;Biochemical Pharmacology;2024-09

2. BCKDK modification enhances the anticancer efficacy of CAR-T cells by reprogramming branched chain amino acid metabolism;Molecular Therapy;2024-09

3. Tertiary lymphoid structures in diseases: immune mechanisms and therapeutic advances;Signal Transduction and Targeted Therapy;2024-08-28

4. Tertiary lymphoid structures in anticancer immunity;Nature Reviews Cancer;2024-08-08

5. Harnessing the tumor microenvironment to boost adoptive T cell therapy with engineered lymphocytes for solid tumors;Seminars in Immunopathology;2024-07-25